Android app Apple app link

Spyre Therapeutics, Inc. (SYRE) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$39.25
Day's range
$41.88

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/09/2026 Robert W. Baird Colleen Kusy $116.00 $90.79   27.77%
08/27/2026 Guggenheim Yatin Suneja $130.00 $93.61   38.88%
08/05/2026 Wedbush David Nierengarten $130.00 $105.83   22.84%
07/13/2026 Mizuho Securities Joseph Catanzaro $120.00 $97.74   22.77%
05/06/2026 Stifel Nicolaus Alex Thompson $107.00 $71.01   50.68%
04/13/2026 Wedbush David Nierengarten $80.00 $63.27   26.44%
04/13/2026 BTIG Julian Harrison $98.00 $63.26   54.92%
11/12/2024 Stifel Nicolaus Alex Thompson $71.00 $35.52   99.89%
10/17/2024 Robert W. Baird Colleen Kusy $50.00 $32.37   54.46%
10/15/2024 Wells Fargo Yanan Zhu $40.00 $30.66   30.46%
05/10/2024 BTIG Julian Harrison $40.00 $35.19   13.67%

Spyre Therapeutics Inc. FAQ's

Spyre Therapeutics Inc. has been rated by research analysts at Robert W. Baird, Guggenheim, Wedbush, BTIG, Deutsche Bank, Wells Fargo in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.